Biologics are made with the help of microorganisms or plant or animal cells, and represent a new and promising tool in the fight against cancer.
As a prestigious brain tumor research center, we provide eligible patients with the latest biologic therapies. We are often one of the first programs in the country offering new treatments, and our team developed the first personalized vaccine for brain tumors, among other accomplishments.
We are part of an elite group of physicians and scientists changing the world of brain tumor care through targeted therapies. Targeted therapies work by altering or destroying specific parts or functions of tumor cells. This approach reduces the risk of harming healthy tissue.
Because of our research, we’re able to offer a broad range of targeted therapies. Options include treatments developed by UCLA Brain Tumor Center experts that are not widely available.
Targeted therapies available at UCLA include:
The UCLA Brain Tumor program is home to one of the nation’s foremost brain tumor immunotherapy researchers. Our efforts have led to novel treatments for complex tumors such as gliomas.
Immunotherapies harness the immune system to boost your body’s natural ability to fight disease. These therapies work by binding to tumors at a molecular level, then destroying them.
Immunotherapies available at UCLA include:
We lead and participate in multi-center trials for developing the next generation of brain cancer immunotherapies. Your physician will let you know if you are eligible for a trial. Learn more about our research and clinical trials.